Literature DB >> 30980950

Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice.

Joonki Kim1, Sharmelee Selvaraji2, Sung Wook Kang2, Wei Thye Lee2, Christopher Li-Hsian Chen3, Hyungwon Choi4, Edward H Koo5, Dong-Gyu Jo6, Kah Leong Lim7, Yun-An Lim2, Thiruma V Arumugam8.   

Abstract

Aggregation of the microtubule-associated protein, tau, can lead to neurofibrillary tangle formation in neurons and glia which is the hallmark of tauopathy. The cellular damage induced by the formation of neurofibrillary tangles leads to neuroinflammation and consecutive neuronal death. However, detailed observation of transcriptomic changes under tauopathy together with the comparison of age-dependent progression of neuroinflammatory gene expressions mediated by tau overexpression is required. Employing RNA sequencing on PS19 transgenic mice that overexpress human mutant tau harboring the P301S mutation, we have examined the effects of age-dependent tau overexpression on transcriptomic changes of immune and inflammatory responses in the cerebral cortex. Compared to age-matched wild type control, P301S transgenic mice exhibit significant transcriptomic alterations. We have observed age-dependent neuroinflammatory gene expression changes in both wild type and P301S transgenic mice where tau overexpression further promoted the expression of neuroinflammatory genes in 10-month old P301S transgenic mice. Moreover, functional gene network analyses (gene ontology and pathway enrichment) and prospective target protein interactions predicted the potential involvement of multiple immune and inflammatory pathways that may contribute to tau-mediated neuronal pathology. Our current study on P301S transgenic mice model revealed for the first time, the differences of gene expression patterns in both early and late stage of tau pathology in cerebral cortex. Our analyses also revealed that tau overexpression alone induces multiple inflammatory and immune transcriptomic changes and may provide a roadmap to elucidate the targets of anti-inflammatory therapeutic strategy focused on tau pathology and related neurodegenerative diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neuroinflammation; P301S; PS19; RNA sequencing; Tauopathy; Transcriptome

Year:  2019        PMID: 30980950     DOI: 10.1016/j.bbi.2019.04.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  2 in total

1.  Transcriptomic analysis highlights cochlear inflammation associated with age-related hearing loss in C57BL/6 mice using next generation sequencing.

Authors:  Zhongwu Su; Hao Xiong; Yi Liu; Jiaqi Pang; Hanqing Lin; Weijian Zhang; Yiqing Zheng
Journal:  PeerJ       Date:  2020-08-19       Impact factor: 2.984

2.  Integrated analysis of the aging brain transcriptome and proteome in tauopathy.

Authors:  Carl Grant Mangleburg; Timothy Wu; Hari K Yalamanchili; Caiwei Guo; Yi-Chen Hsieh; Duc M Duong; Eric B Dammer; Philip L De Jager; Nicholas T Seyfried; Zhandong Liu; Joshua M Shulman
Journal:  Mol Neurodegener       Date:  2020-09-29       Impact factor: 14.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.